HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Plasma kallikrein clearance by the liver in experimental cirrhosis].

AbstractAIM:
To study the hepatic clearance of a glycoprotein (rat plasma kallikrein) by the liver of rats with experimental decompensated cirrhosis.
MATERIAL AND METHODS:
Cirrhosis was induced by intragastrically administration of carbon tetrachloride 520 mg/kg/week, during 16-19 weeks. After this period, each liver was isolated, exsanguinated and perfused at 37 degrees C with 10nM rat plasma kallikrein (RPK).
RESULTS:
58% of the animals died during the treatment and the remaining developed prostration, ascites, jaundice and bleeding; at the end of the treatment period serum aminotransferases were not altered and serum albumin decreased. The liver histology showed cirrhosis. RPK clearance rate of the cirrhosis group (5.4 +/- 0.9 pmol/g liver/10 min) was significantly lower (p < 0.05) than that of the control group (13.5 +/- 2.7 pmol/g liver/10 min).
CONCLUSION:
The development of cirrhosis is associated with a decreased hepatic clearance of a glycoprotein which endocytosis is mediated by a receptor.
AuthorsC F de Toledo, M R Loureiro-Silva, H M Molina, V P Lanzoni, M Kouyoumdjian, D R Borges
JournalRevista da Associacao Medica Brasileira (1992) (Rev Assoc Med Bras (1992)) 1995 Nov-Dec Vol. 41 Issue 6 Pg. 367-72 ISSN: 0104-4230 [Print] Brazil
Vernacular TitleDepuração hepática da calicreína plasmática na cirrose experimental.
PMID8733244 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Carbon Tetrachloride
  • Kallikreins
Topics
  • Age Factors
  • Analysis of Variance
  • Animals
  • Body Weight (drug effects)
  • Carbon Tetrachloride (administration & dosage)
  • Kallikreins (metabolism)
  • Liver (metabolism)
  • Liver Cirrhosis, Experimental (physiopathology)
  • Metabolic Clearance Rate
  • Organ Size (drug effects)
  • Perfusion
  • Prognosis
  • Rats
  • Rats, Wistar

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: